Is the Bayer-Monsanto Merger too big to succeed? - Chicago Tribune

Chicago TribuneIs the Bayer-Monsanto Merger too big to succeed?Chicago TribuneIt took $66 billion - the largest all-cash transaction in history - for German biotech giant Bayer to win control over Monsanto, the global seed market leader. The takeover creates a very unique - and to some, very unsettling - kind of corporate beast ...Bayer clinches Monsanto with improved $66 billion bidReutersall 237 news articles »

CPI Jump Weighs on Dow Jones Industrial Average Futures - Schaeffers Research (blog)

CPI Jump Weighs on Dow Jones Industrial Average FuturesSchaeffers Research (blog)The Chicago Board Options Exchange (CBOE) saw 949,130 call contracts traded on Thursday, compared to 667,398 put contracts. The resultant single-session equity put/call ratio rose to 0.70, while the 21-day ... Novavax, Inc. (NASDAQ:NVAX) is the latest ...and more »

Intarcia kicks off new funding that could bring $4b valuation - The Boston Globe

Intarcia kicks off new funding that could bring $4b valuationThe Boston GlobeWhen the second stage closes in the fourth quarter, Intarcia's overall funding will total more than $1.5 billion from private investors ranging from Boston giants Fidelity Investments and Baupost Group to Chicago's Pritzer Organization and China's ...and more »

Bayer, Monsanto confront global review as farmer options shrink - Chicago Tribune

NDTVBayer, Monsanto confront global review as farmer options shrinkChicago TribuneBiotech crops, the result of decades of development and billions of dollars in investment, have increased farm productivity and in many cases led to lower prices for consumers. At the same time, critics say, crop diversity has declined and small-scale ...Bayer clinches Monsanto with improved $66 billion bidReutersall 656 news articles »

U.S. stocks slide the most since Brexit amid rate speculation - Chicago Tribune

U.S. stocks slide the most since Brexit amid rate speculationChicago Tribune"Boring utilities and other defense trades started behaving like Apple in the glory days or hot biotech stocks, and it attracted momentum players, so that's another factor embedded in this," Michael Purves, chief global strategist at Weeden & CO in ...and more »

Inside Hopcat's new Chicago location - MLive.com

MLive.comInside Hopcat's new Chicago locationMLive.com"They are in fun places so we can turn it into a fun trip," said Kurihara, 49, an operations manager for a biotech company. He got hooked on attending HopCat openings after going to the ones closer to home in Ann Arbor and Detroit. Kurihara joked that ...

Drug industry group starts ad campaign to push back on pricing - Chicago Tribune

Drug industry group starts ad campaign to push back on pricingChicago Tribune"We're under pressure and scrutiny like never before," said Jim Greenwood, chief executive officer of the Biotechnology Innovation Organization. The campaign, called "Innovation Saves," says new drugs can save both lives and costs to the health-care ...and more »

AbbVie: Not Your Father's Biotech Company? - Barron's (blog)

AbbVie: Not Your Father's Biotech Company?Barron's (blog)Not your father's biotech company. Having spun out of Abbott Laboratories (ABT) in 2013, and based in North Chicago, IL, AbbVie comes with a decidedly different pedigree than most biotechs. Indeed, most investors we speak with tend to lump the company ...and more »

Clinton's attacks on drug prices leave health stocks reeling - Chicago Tribune

TIMEClinton's attacks on drug prices leave health stocks reelingChicago TribuneHer remarks, calling Mylan the "latest troubling example of a company taking advantage of its consumers," also sent the broader 144-member Nasdaq Biotechnology Index tumbling as much as 3.6 percent Wednesday. Mylan didn't respond to requests for ...Mylan says it will expand programs that lower EpiPen costsFox 32 ChicagoMylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector ...MylanMylan CEO Bresch: 'No one's more frustrated than me' about EpiPen price furorCNBCall 1,308 news articles »

Court to hear whistleblower's case alleging Celgene's aggressive push of Thalidomide - Chicago Tribune

Chicago TribuneCourt to hear whistleblower's case alleging Celgene's aggressive push of ThalidomideChicago TribuneIn the 1990s, Celgene was a small biotech firm that had never brought a drug to market. A study showed thalidomide, then being used to treat leprosy overseas, might help against HIV-related weight loss. Researchers found the compound tied to birth ...and more »

Home care company wants to open 26 franchises here - Philadelphia Business Journal

Philadelphia Business JournalHome care company wants to open 26 franchises herePhiladelphia Business Journal... worked in the financial services industry. Based in Chicago, BrightStar Care has more than 300 locations across the county and generates annual sales of $335 million. John George covers health care, biotech/pharmaceuticals and sports business.and more »

Midwest healthcare startups raise record-breaking $1 billion in first half of 2016 - cleveland.com

cleveland.comMidwest healthcare startups raise record-breaking $1 billion in first half of 2016cleveland.com"This is the first time since BioEnterprise began compiling this report in 2005 that the software and services sector has outpaced the biotech and medical device sectors in terms of funds raised and number of companies raising the funds," said Annette ...

Buzz Stocks: Twitter Inc, Tesla Motors Inc, and Aurinia Pharmaceuticals Inc - Schaeffers Research (blog)

Schaeffers Research (blog)Buzz Stocks: Twitter Inc, Tesla Motors Inc, and Aurinia Pharmaceuticals IncSchaeffers Research (blog)A rise in crude oil prices and stimulus hopes out of China have U.S. stocks set to open higher this morning. Among equities in focus today are microblogging concern Twitter Inc (NYSE:TWTR), electric car maker Tesla Motors Inc (NASDAQ:TSLA), and biotech ...and more »

Japanese reporters travel to the US to learn about biotech, biofuels - High Plains Journal

Japanese reporters travel to the US to learn about biotech, biofuelsHigh Plains JournalThe Illinois portion of the tour concluded with a visit to the University of Illinois at Chicago to meet with Steffen Mueller from the Energy Resources Center at UIC and Gerard Ostheimer from the United Nations Sustainable Energy For All Initiative.

Tech and Biotech: gBETA and Madworks graduate startup classes; Zurex draws $6 million - Madison.com

Madison.comTech and Biotech: gBETA and Madworks graduate startup classes; Zurex draws $6 millionMadison.comIn the past, Zurex has raised more than $10 million, with investors that included the State of Wisconsin Investment Board; members of Wisconsin Investment Partners; Baird Venture Partners, Chicago; and Peak Ridge Capital, with offices in Boston ...